|
BASF starts work on vitamin B plant in Korea...Obtains license for THF complex in Shanghai. (New Construction Projects).(Brief Article)
From:
Chemical Week
| Date:
September 18, 2002
| COPYRIGHT 2002 Chemical Week Associates. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
BASF says it will close its lysine plant at Gunsan, Korea in October for about six weeks for the installation of a previously announced 3,000-m.t./year vitamin B2 plant (CW, Oct. 31, 2001, p. 17). The two units share the utilities. The company has 100,000 m.t./year of lysine capacity at Gunsan, its only production sire. BASF says the shutdown is likely to cause a shorta...
Related newspaper, magazine, and journal articles from HighBeam Research
|
BASF: Sticking to its Guns.(Interview)
Chemical Week
; Benefits from 'Verbund' BASF IS RESHAPING ITS PORTFOLIO in response to structural changes that have swept the chemical industry since the early l990s. Still, the company has not fundamentally changed course. BASF has stuck to its long-term strategy of Verbund, or total integration, rather than opt
|
|
BASF starts work on vitamin B plant in Korea...Obtains license for THF complex in Shanghai. (New Construction Projects).(Brief Article)
Chemical Week
; BASF says it will close its lysine plant at Gunsan, Korea in October for about six weeks for the installation of a previously announced 3,000-m.t./year vitamin B2 plant (CW, Oct. 31, 2001, p. 17). The two units share the utilities. The company has 100,000 m.t./year of lysine capacity at Gunsan, its
|
|
Managing the business cycle at BASF: gas deal provides hope for improving results. (Company Profile)
Chemical Week
; Gas deal provides hope for improving results With sales of more than DM46.6 billion ($29.2 billion) last year, BASF (Ludwigshafen) ranks among the top three chemical companies worldwide. Its size and position, however, have not shielded the company from the rough economic weather. In fact, BASF has
|
|
BASF becomes a major U.K. producer: PP acquisition reinforces presence. (acquisition of Imperial Chemical Industries PLC's polypropylene capacity) (Country Focus: United Kingdom)
Chemical Week
; For BASF in the U.K., 1994 is shaping up as a memorable year. On March 1, the company acquired ICI's 150,000-m.t./year polypropylene (PP) capacity at Wilton, Teesside, part of a bigger deal that doubled BASF's PP capacity, to 600,000 m.t./year. Barry Stickings, BASF's regional managing director
|
|
BASF Launches Cost Savings Plan, Warns on 1999 Earnings.
Chemical Week
; Basf announced a dm900-million ($500 million) cost savings plan last week that will be implemented during 1999. Chairman Jurgen Strube, citing weak economic conditions outside North America, warns that BASF's 1999 earnings will fall and sales will be flat. Of the announced savings, DM250 million
|
|
BASF Restructures Pharmaceuticals; Seeks Agchems Acquisition.
Chemical Week
; Basf is planning to combine its global pharmaceuticals operations into one legal entity that will be headquartered in London. The business will be headed by Thorlef Spickschen, president of BASF's pharmaceuticals division. The new structure, which will begin operating next month, will allow BASF to
|
|
BASF May Swap Drugs for Pesticides.(Brief Article)(Statistical Data Included)
Chemical Week
; BASF is considering divesting its pharmaceuticals business, or the company may swap its drugs activities for another company's crop protection business, sources say. BASF is facing difficulties in pharmaceuticals because of its small size, says CFO Max Dietrich Kley. The company is the world's 30th
|
|
BASF Aligns R&D With Sustainable Development.(research and development to be aligned with environmentally sustainable activities)
Chemical Week
; BASF'S PUSH TO foster environmentally sustainable activities is prompting a change in its research effort, says Stefan Marcinowski, BASF board member responsible for R&D. Underlying BASF's strategy is the premise that its products will have a commercial advantage if they perform at the same
|
|
BASF Warns on 1999 and Energy Tax, Plans Ventures with Gazprom.
Chemical Week
; Basf warned last week that its profits will decline in 1999. The year ahead is unlikely to see any new records, because of the impact of the financial and economic crises in emerging markets, along with the expected slowdown in the European and U.S. economies, says CEO J\252rgen Strube. There has
|
|
BASF Bags Cyanamid for $3.8 Billion.
Chemical Week
; BASF has outbid a group of leading agchem players to acquire American Home Products' (AHP) agchems business, American Cyanamid, with a $3.8- billion cash offer-significantly above AHP's rumored asking price of $3 billion. Analysts expected AHP to have difficulty in meeting that target, but they say
|